ARCHIVES

FDA Moves To Revoke Avastin’s Breast Cancer Accelerated Approval, Genentech Vows To Fight

This article is from The Cancer Letter archive.

Vol. 36 No. 46 | December 17, 2010

Download PDF Visit The Full Archive

Related Articles

DCPC Advisors Begin Process Of Setting Priorities For Research

June 21, 1991

Brinker Again To Lead Komen As CEO

December 11, 2009

Women Radiated For Wilms’ At Risk For Complications In Pregnancy, Study Finds

May 31, 2002

The FY 1984 Bypass Budget: How NCI Would Spend the Money

July 9, 1982

NCI Implements Changes To Speed Up New Drug Development; compounds In Pipeline Listed

July 9, 1976

UICC Fellowship, Exchange Programs

July 5, 1985